Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Chiara DI Chio

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|July 16, 2016
Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphomaChiara De Philippis, Maria Chiara Di Chio, Elena Sabattini, et al.
Platelets|September 24, 2020
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic reviewGian Marco Podda, Elisa M Fiorelli, Simone Birocchi, et al.
Intractable & Rare Diseases Research|October 25, 2014
Anti-cytokine treatment for Takayasu arteritis: State of the artEnrico Tombetti, Maria Chiara Di Chio, Silvia Sartorelli, et al.
Leukemia & Lymphoma|May 3, 2018
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survivalFrancesco Spina, Tommaso Radice, Chiara De Philippis, et al.
Frontiers in Immunology|June 14, 2019
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated DiseasesGiuseppe A Ramirez, Patrizia Rovere-Querini, Miriam Blasi, et al.
Frontiers in Immunology|August 10, 2019
Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated DiseasesGiuseppe A Ramirez, Patrizia Rovere-Querini, Miriam Blasi, et al.
Arthritis Research & Therapy|November 15, 2014
Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritisEnrico Tombetti, Maria Chiara Di Chio, Silvia Sartorelli, et al.
British Journal of Haematology|June 15, 2024
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE studyAngelica Barone, Annalisa Chiappella, Beatrice Casadei, et al.
Arthritis Research & Therapy|August 18, 2016
Chromogranin-A production and fragmentation in patients with Takayasu arteritisEnrico Tombetti, Barbara Colombo, Maria Chiara Di Chio, et al.
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|July 16, 2016
Bowel perforation from occult ileal involvement after diagnosis in a case of primary mediastinal large B-cell lymphomaChiara De Philippis, Maria Chiara Di Chio, Elena Sabattini, et al.
Platelets|September 24, 2020
Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic reviewGian Marco Podda, Elisa M Fiorelli, Simone Birocchi, et al.
Intractable & Rare Diseases Research|October 25, 2014
Anti-cytokine treatment for Takayasu arteritis: State of the artEnrico Tombetti, Maria Chiara Di Chio, Silvia Sartorelli, et al.
Leukemia & Lymphoma|May 3, 2018
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survivalFrancesco Spina, Tommaso Radice, Chiara De Philippis, et al.
Frontiers in Immunology|June 14, 2019
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated DiseasesGiuseppe A Ramirez, Patrizia Rovere-Querini, Miriam Blasi, et al.
Frontiers in Immunology|August 10, 2019
Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated DiseasesGiuseppe A Ramirez, Patrizia Rovere-Querini, Miriam Blasi, et al.
Arthritis Research & Therapy|November 15, 2014
Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritisEnrico Tombetti, Maria Chiara Di Chio, Silvia Sartorelli, et al.
British Journal of Haematology|June 15, 2024
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE studyAngelica Barone, Annalisa Chiappella, Beatrice Casadei, et al.
Arthritis Research & Therapy|August 18, 2016
Chromogranin-A production and fragmentation in patients with Takayasu arteritisEnrico Tombetti, Barbara Colombo, Maria Chiara Di Chio, et al.
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
Pageof 2